Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

Th. Büchner, D. Urbanitz, Wolfgang Hiddemann, +7

Journal of Clinical Oncology

Mixed-phenotype Acute LeukemiaImmunologyPharmacotherapyMyeloid NeoplasiaHematological Malignancy +15

Improved outcome in adult B-cell acute lymphoblastic leukemia

D. Hoelzer, WD Ludwig, E. Thiel, +21

Blood

A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia

Walter Fiedler, Rolf M. Mesters, Heike Tinnefeld, +15

Blood

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

Nicolaus Kröger, Rainer Schwerdtfeger, Michael Kiehl, +8

Blood

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

P. Meusers, M. Engelhard, H. Bartels, +21

Hematological Oncology

Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.

A.C. Feller, H Griesser, C V Schilling, +6

PubMed

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Michael Stadler, Ulrich Germing, Kliche Ko, +12

Leukemia

Equine-assisted TherapyAnimal HealthBone Marrow FailureAnimal ScienceHematology +12

Treatment of Angioimmunoblastic Lymphadenopathy (AILD)-Type T-Cell Lymphoma Using Prednisone with or without the COPBLAM/IMVP-16 Regimen

W. Siegert, Alexander G Agthe, Henrik Griesser, +7

Annals of Internal Medicine

Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.

M Körbling, Rolf Holle, Rainer Haas, +7

Journal of Clinical Oncology

Cell TherapyImmunologyPathologyImmunotherapyRegenerative Medicine +19

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

Michael Hallek, Barbara Schmitt, Martin Wilhelm, +17

British Journal of Haematology